
EAG Life Sciences specializes in supporting stand-alone projects with our extensive proprietary method library or by developing and validating methods to meet your needs. Our GLP compliant operations are equipped to analyze biological samples for drug candidates and metabolites in biological matrices such as blood, plasma, urine, dialysate and tissues to support preclinical pharmacodynamics, pharmacokinetic, toxicology research and clinical programs.
Our experienced team is capable of rapidly solving complex bioanalytical problems by developing and validating robust quantitative methods including cross-matrix methods and applying those methods to high-throughput sample analysis. We are dedicated to providing 100% GLP compliant services that meet regulatory standards and exceed your expectations. We offer analytical support of your GLP and non-GLP studies including method development, validation, sample analysis, quality assurance, data reporting and management.
EAG's bioanalytical capabilities include: